Oscar Health, Inc. OSCR

Financials SIC 6324 - Hospital & Medical Service Plans NAICS Finance and Insurance › Insurance Carriers and Related Activities › Insurance Carriers derived NYSE

Oscar is a leading healthcare technology company built around a full stack technology platform and a relentless focus on member experience. We offer health plans through the ACA serving individuals, families, and employees. We have been challenging the status quo in the healthcare system since our founding in 2012 and are dedicated to making a healthier life accessible and affordable for all. Our technology drives superior experiences, deep engagement, and high-value clinical care, earning us the trust of approximately 2.0 million effectuated members, as of December 31, 2025. Effectuated members are those who are actively enrolled in our plan and have either paid their premium or are within the grace period.

Last close 30.99 2026-10-23
Market cap $9.37B estimated share count
52-week range 10.69 - 35.01

Valuation FY2025 figures against the last close

P/S327.6x
P/E—
P/FCF8.8x
EV/EBITDA—
Dividend yield—
Diluted EPS-1.69

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue $28.6M$20.6M$21.4M$64.9M$5.4M$0$488.2M—
SG&A $2.05B$1.76B$1.43B$1.26B$265.1M$166.7M$110.7M—
Operating income -$396.4M$57.3M-$235.6M-$589.9M-$544.5M-$402.3M-$259.4M—
Interest expense $17.6M$23.7M$24.6M$22.6M$4.7M$3.5M$0—
Pre-tax income -$437.3M$33.4M-$267.3M-$610.1M-$570.6M-$405.8M-$259.4M—
Income tax $5.6M$7.3M$3.3M$523.0K$846.0K$1.0M$1.8M—
Net income -$442.9M$26.1M-$270.6M-$609.6M-$571.4M-$406.8M-$261.2M—
EPS, basic -1.690.11-1.22-2.85-3.20-14.16-9.06—
EPS, diluted -1.690.10-1.22-2.85-3.20-14.16-9.06—
Shares, diluted (wtd. avg.) 262.4M265.9M221.7M212.5M179.0M29.3M28.8M—

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents $2.77B$1.53B$1.87B$1.58B$1.13B$843.1M$353.4M$370.4M
Short-term investments $1.22B$624.5M$689.8M$1.40B$587.1M$366.4M——
Total current assets $4.61B$2.85B$3.06B$4.12B$2.31B$1.87B——
Property, plant and equipment $88.3M$66.8M$61.9M$59.9M$46.6M$35.8M——
Total assets $6.33B$4.84B$3.60B$4.53B$3.32B$2.27B——
Accounts payable $649.7M$432.4M$273.4M$297.8M$234.8M$137.5M——
Total current liabilities $4.86B$3.46B$2.43B$3.26B$1.85B$1.67B——
Long-term debt $430.1M$299.6M$298.8M$298.0M$0$142.5M——
Total liabilities $5.34B$3.82B$2.80B$3.63B$1.93B$1.82B——
Retained earnings -$3.29B-$2.85B-$2.88B-$2.61B-$2.00B-$1.43B——
Total equity $977.6M$1.01B$806.1M$892.4M$1.39B-$1.30B$0—

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Operating cash flow $1.09B$978.2M-$272.2M$380.3M-$181.7M$222.7M-$165.4M—
Depreciation and amortisation $28.9M$32.1M$30.7M$15.3M$14.6M$11.3M$6.9M—
Stock-based compensation $87.7M$109.8M$159.7M$112.3M$86.3M$35.9M$33.6M—
Capital expenditure $36.4M$27.9M$25.6M$29.0M$25.9M$14.0M$26.0M—
Investing cash flow -$241.1M-$1.39B$577.2M-$226.5M-$774.5M-$344.7M$150.5M—
Financing cash flow $399.2M$68.4M$6.4M$301.1M$1.24B$611.7M-$2.1M—
Buybacks ————$0$0$3.0M—

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001140361-26-016119.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -1B -500M 0 500M Revenue, FY2019: 488.2M Net income, FY2019: -261.2M Revenue, FY2020: 0 Net income, FY2020: -406.8M Revenue, FY2021: 5.4M Net income, FY2021: -571.4M Revenue, FY2022: 64.9M Net income, FY2022: -609.6M Revenue, FY2023: 21.4M Net income, FY2023: -270.6M Revenue, FY2024: 20.6M Net income, FY2024: 26.1M Revenue, FY2025: 28.6M Net income, FY2025: -442.9M FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue — $488.2M $0 $5.4M $64.9M $21.4M $20.6M $28.6M
Gross profit — — — — — — — —
Net income — -$261.2M -$406.8M -$571.4M -$609.6M -$270.6M $26.1M -$442.9M

Recent filings and events

  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Results announced Item 2.02
  • Regulation FD disclosure Item 7.01
  • Regulation FD disclosure Item 7.01
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
  • Results announced Item 2.02
  • New debt or obligation The company has taken on debt or a comparable obligation. Item 2.03
  • Officer or director change Item 5.02

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 6324

TickerCompanyMarket capP/ERevenue growth
UNH UNITEDHEALTH GROUP INC $375.28B 31.6x 11.8%
ELV Elevance Health, Inc. $95.41B 17.5x 12.5%
CI Cigna Group $81.11B 13.8x 11.2%
HUM HUMANA INC $50.67B 42.9x 31.6%
CNC CENTENE CORP $34.66B — 20.0%
MOH MOLINA HEALTHCARE, INC. $10.92B 23.4x 11.7%
CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE $2.41B — 40.3%
ALHC Alignment Healthcare, Inc. $1.67B — 46.1%